Search results
3 days ago · Kyowa Kirin Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical and biochemical products. Net sales break down by source of revenue as follows: - sales of pharmaceutical products (92.6%): prescription products for anemia, cancers, immune and nephrology diseases treatment; - sales of licenses (7.4%).
Jun 10, 2024 · Who is Kyowa Kirin. Kyowa Kirin is a global specialty pharmaceutical company focused on antibody research and engineering to address the needs of patients and society across multiple therapeutic areas, including Nephrology, Oncology, Immunology/Allergy and Neurology. They are headquartered in Tokyo, Japan. Read more. Kyowa Kirin's Social Media
1 day ago · Over 3,160 companies were considered in this analysis, and 3,042 had meaningful values. The average Market Cap of companies in the Sector is 120.4 B with a standard deviation of 413.6 B. Kyowa Kirin Co Ltd's Market Cap of 1,535.4 B ranks in the 96.2% percentile for the Sector. The following table provides additional summary stats:
Jun 10, 2024 · Kyowa Kirin's investment of up to $530 million will be supported by performance-based state and local incentives to Kyowa Kirin of $10 million over 12 years, which are estimated to grow the state ...
Jun 10, 2024 · Kyowa Kirin's investment of up to $530 million will be supported by performance-based state and local incentives to Kyowa Kirin of $10 million over 12 years, which are estimated to grow the state ...
Jun 28, 2024 · Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central ...
Jun 17, 2024 · Kyowa Kirin overview. Kyowa Kirin, a subsidiary of Kirin Holdings Co Ltd, is a biotechnology company focused on research and development. It is involved in the discovery, development, production and commercialization of pharmaceuticals and biotechnology products.
